Overview:
70% of clinical research sites report an increase in study execution burden, but when investigators have a superior experience with a sponsor they may enroll twice as many patients1.
This webinar will present evidence-based strategies to become partner of choice for high-performing sites by easing the site burden2 while making clinical trials more efficient. This includes optimising site feasibility and activation, improving staff training and study compliance, and early engagement with sites to improve their understanding of the study protocol. Global case studies will be shared, showing how these strategies allow for wider access to clinical trials and accelerated study start-up and enrolment.
1 Tufts Report, Volume 25, Number 1, Jan/Feb 2023
2 The Clinical Trial Challenge: To Win Patients, Win Over Physicians | Bain & Company
Speakers:
Ana Fernandez-Ramos, PhD
Ana is the Lead Clinical Trial Liaison (CTL) for Europe, currently leading CTL activities for multiple projects at ICON, with over 7 years CRO experience. PhD trained with academic, industry and international site experience, Ana is highly skilled in providing clinical trial strategy for sponsors and cultivating site relationships, impacting trial efficiency and improving patient recruitment. She’s experienced in national and international scientific conferences and workshops, delivering audience-specific scientific presentations to both scientific and non-scientific audiences. Ana’s background is in novel pharmacological targets for solid transplants, but she has clinical expertise in vaccine trials, hematology, immunology (CD, UC, Lupus), chronic kidney disease, neurology (Alzheimer’s disease), solid cancers, and others.
Manuel Rodriguez, MD
Dr. Rodriguez serves as the Primary Investigator at the Florida Research Institute (FRI), where he leads a dedicated team in coordinating innovative clinical studies. With a commitment to advancing overall health, Dr. Rodriguez plays a pivotal role in highlighting FRI’s efforts to improve health outcomes through rigorous clinical trial research, having completed over 30 trials including fatty liver disease, cirrhosis, IBS, IBD, weight management, cancer screening, NSAID induced GI diseases, and device trials among others. His leadership and expertise contribute significantly to the institute’s mission of enhancing health and medical knowledge.
Dr. Rodriguez is board certified in Internal Medicine and Gastroenterology. He completed his residency and internship at University of Miami, Jackson Memorial Hospital and his fellowship at University of Texas, MD Anderson Cancer Center. Dr Rodriguez holds many professional memberships, including the American Society for Gastrointestinal Endoscopy, American Gastroenterology Association, American College of Gastroenterology.